Effect of Telerehabilitation-Based Exercise and Motor Imagery Training in Children With ADHD
NCT05208255, Not applicable, Completed, Izmir Katip Celebi University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effect of Telerehabilitation-Based Exercise and Motor Imagery Training in Children With ADHD | ClinicalTrials.gov |
| NCT number | NCT05208255 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 33 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Izmir Katip Celebi University | ClinicalTrials.gov |
| Conditions | Adhd | ClinicalTrials.gov |
| Interventions | Exercise | ClinicalTrials.gov |
| First posted | 2022-01-26 | ClinicalTrials.gov |
| Last updated | 2025-06-06 | ClinicalTrials.gov |
Registered outcomes 18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Conners Parent Rating Scale-Revised Short | pre-intervention | It determines the severity of ADHD symptoms. The scale consists of three sub-scales (Oppositional Defiant, Cognitive Problems-Inattention, Hyperactivity) and an auxiliary scale (ADHD Index). The questions are answered by the parents on a four-point Likert scale as "Never", "rarely", "often", and "always" which are scored as "0", "1", "2", and "3", respectively. | ClinicalTrials.gov |
| Primary | Conners Parent Rating Scale-Revised Short | within the first week post-intervention | It determines the severity of ADHD symptoms. The scale consists of three sub-scales (Oppositional Defiant, Cognitive Problems-Inattention, Hyperactivity) and an auxiliary scale (ADHD Index). The questions are answered by the parents on a four-point Likert scale as "Never", "rarely", "often", and "always" which are scored as "0", "1", "2", and "3", respectively. | ClinicalTrials.gov |
| Primary | Stroop Test | pre-intervention | The Stroop Test is a task assessing executive function involving processing speed, concentration, and selective attention. Stroop Test was applied in five sections. These sections and related cards are as follows in their application order: (1) The card with the color names printed in black (1st card); (2) the card with the color names printed in different colors (2nd card); (3) the card with the colored printed circles (3rd card); (4) in the card with neutral words without the color name (4th Card); (5) the section where the colors of the words in the 2nd Card are spelt, with the names of colors printed in different colors. | ClinicalTrials.gov |
| Primary | Stroop Test | within the first week post-intervention | The Stroop Test is a task assessing executive function involving processing speed, concentration, and selective attention. Stroop Test was applied in five sections. These sections and related cards are as follows in their application order: (1) The card with the color names printed in black (1st card); (2) the card with the color names printed in different colors (2nd card); (3) the card with the colored printed circles (3rd card); (4) in the card with neutral words without the color name (4th Card); (5) the section where the colors of the words in the 2nd Card are spelt, with the names of colors printed in different colors. | ClinicalTrials.gov |
| Primary | d2 Test of Attention | pre-intervention | The d2 Test measures processing speed, rule compliance, and quality of performance, allowing for a neuropsychological estimation of individual attention and concentration performance. | ClinicalTrials.gov |
| Primary | d2 Test of Attention | within the first week post-intervention | The d2 Test measures processing speed, rule compliance, and quality of performance, allowing for a neuropsychological estimation of individual attention and concentration performance. | ClinicalTrials.gov |
| Primary | Y Balance Test | pre-intervention | Y-Balance Test is used to evaluate the dynamic balance. YBT is performed in three directions (anterior, posteromedial, and posterolateral). | ClinicalTrials.gov |
| Primary | Y Balance Test | within the first week post-intervention | Y-Balance Test is used to evaluate the dynamic balance. YBT is performed in three directions (anterior, posteromedial, and posterolateral). | ClinicalTrials.gov |
| Primary | Timed Up and Go Test | pre-intervention | The Timed Up and Go Test, which is found an excellent level of validity and reproducibility by Nicolini and Donadio, is performed as the standard test protocol applied in children to evaluate dynamic balance and functionality. | ClinicalTrials.gov |
| Primary | Timed Up and Go Test | within the first week post-intervention | The Timed Up and Go Test, which is found an excellent level of validity and reproducibility by Nicolini and Donadio, is performed as the standard test protocol applied in children to evaluate dynamic balance and functionality. | ClinicalTrials.gov |
| Secondary | Movement Imagery Questionnaire-Revised Second Edition | pre-intervention | The Motion Imagery Questionnaire-Revised Second Edition will be used to measure children's visual and kinesthetic visualization skills. It consists of 14 items, seven of which are visual and 7 of which are kinesthetic. During the test, children scores by asking them to perform the actions in the instruction once in reality, then to visualize the movement they do and to indicate the clarity of this imagery on a Likert-type scale from 1 (Very difficult to feel/see) to 7 (Very easy to feel/see). | ClinicalTrials.gov |
| Secondary | Movement Imagery Questionnaire-Revised Second Edition | within the first week post-intervention | The Motion Imagery Questionnaire-Revised Second Edition will be used to measure children's visual and kinesthetic visualization skills. It consists of 14 items, seven of which are visual and 7 of which are kinesthetic. During the test, children scores by asking them to perform the actions in the instruction once in reality, then to visualize the movement they do and to indicate the clarity of this imagery on a Likert-type scale from 1 (Very difficult to feel/see) to 7 (Very easy to feel/see). | ClinicalTrials.gov |
| Secondary | Kinesthetic and Visual Imagery Ouestionnaire | pre-intervention | The form consists of a total of 10 movements that measure five visual and five kinesthetic visualization skills developed to determine the extent to which individuals visualize and feel the imagined movements. The evaluator performs the relevant move on himself and then asks the participant to do the same movement only once. Then, the participant imagines the movement, and the visual clarity of the imaged movement or the senses are scored with the help of a 5-point ordinal scale. | ClinicalTrials.gov |
| Secondary | Kinesthetic and Visual Imagery Ouestionnaire | within the first week post-intervention | The form consists of a total of 10 movements that measure five visual and five kinesthetic visualization skills developed to determine the extent to which individuals visualize and feel the imagined movements. The evaluator performs the relevant move on himself and then asks the participant to do the same movement only once. Then, the participant imagines the movement, and the visual clarity of the imaged movement or the senses are scored with the help of a 5-point ordinal scale. | ClinicalTrials.gov |
| Secondary | Timed Up and Go-Mental Chronometer | pre-intervention | This test will be performed while sitting position in a chair at the beginning of the Timed Get Up and Go Test track. Individuals are asked to complete the TUG by imagining with their eyes closed, and the time to complete the test is recorded with a chronometer. The temporal coherence between the real and the imagined movement is calculated in terms of delta time with the formula '(real motion-imagined motion) / \[(real motion+imagined motion) / 2\] x 100'. | ClinicalTrials.gov |
| Secondary | Timed Up and Go-Mental Chronometer | within the first week post-intervention | This test will be performed while sitting position in a chair at the beginning of the Timed Get Up and Go Test track. Individuals are asked to complete the TUG by imagining with their eyes closed, and the time to complete the test is recorded with a chronometer. The temporal coherence between the real and the imagined movement is calculated in terms of delta time with the formula '(real motion-imagined motion) / \[(real motion+imagined motion) / 2\] x 100'. | ClinicalTrials.gov |
| Secondary | Ruler Drop Test | pre-intervention | It is a simple and inexpensive test used to evaluate the hand reaction time. For the test, a 50 cm ruler will be used. During the test, the person is asked to sit comfortably with his dominant arm on the table. The practitioner randomly leaves the ruler at hand level for 2-5 seconds, and the person is asked to grasp the ruler as quickly as possible. The distance the person has caught the ruler is recorded. The average of three measurements made after two trial tests will be taken as the test value. | ClinicalTrials.gov |
| Secondary | Ruler Drop Test | within the first week post-intervention | It is a simple and inexpensive test used to evaluate the hand reaction time. For the test, a 50 cm ruler will be used. During the test, the person is asked to sit comfortably with his dominant arm on the table. The practitioner randomly leaves the ruler at hand level for 2-5 seconds, and the person is asked to grasp the ruler as quickly as possible. The distance the person has caught the ruler is recorded. The average of three measurements made after two trial tests will be taken as the test value. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Cancellation Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)